Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells
Advanced Biology · 2024
DOI: 10.1002/adbi.202300403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Xinmei Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Centre, the Third Affiliated Hospital, Sun Yat-sen University, 600# Tianhe Road, Guangzhou, 510630, China. Hauptthemen laut MEDLINE: CDC2 Protein Kinase, Hepatic Stellate Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangzhou Science and Technology Project.
Abstract (Originalsprache)
Liver fibrosis is the integral process of chronic liver diseases caused by multiple etiologies and characterized by excessive deposition of extracellular matrix (ECM). During liver fibrosis, hepatic stellate cells (HSCs) transform into a highly proliferative, activated state, producing various cytokines, chemokines, and ECM. However, the precise mechanisms that license HSCs into the highly proliferative state remain unclear. Cyclin‐dependent kinase 1 (CDK1) is a requisite event for the transition of the G1/S and G2/M phases in eukaryotic cells. In this study, it is demonstrated that CDK1 and its activating partners, Cyclin A2 and Cyclin B1, are upregulated in both liver fibrosis/cirrhosis patient specimens and the murine hepatic fibrosis models, especially in activated HSCs. In vitro, CDK1 is upregulated in spontaneously activated HSCs, and inhibiting CDK1 with specific small‐molecule inhibitors (CGP74514A, RO‐3306, or Purvalanol A) orshort hairpin RNAs (shRNAs) resulted in HSC apoptosis and cell cycle arrest by regulating Survivin expression. Above all, it is illustrated that increased CDK1 expression licenses the HSCs into a highly proliferative state and can serve as a potential therapeutic target in liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Centre, the Third Affiliated Hospital, Sun Yat-sen University, 600# Tianhe Road, Guangzhou, 510630, China.
- Cell-gene Therapy Translational Medicine Research Centre, the Third Affiliated Hospital, Sun Yat-sen University, 600# Tianhe Road, Guangzhou, 510630, China.
- Guangdong Provincial Key Laboratory of Liver Disease Research, the Third Affiliated Hospital, Sun Yat-sen University, 600# Tianhe Road, Guangzhou, 510630, China.
ORCID-Profile: Yan Xu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangzhou Science and Technology Project
- Medical Scientific Research Foundation of Guangdong Province
- Chinese Postdoctoral Science Foundation
Zitieren
APA
Kang, X., Chen, H., Zhou, Z., Tu, S., Cui, B., Li, Y., Dong, S., Zhang, Q., & Xu, Y. (2024). Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells. Advanced Biology. https://doi.org/10.1002/adbi.202300403
Vancouver
Kang X, Chen H, Zhou Z, Tu S, Cui B, Li Y, et al. Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells. Advanced Biology. 2024. doi:10.1002/adbi.202300403
BibTeX
@article{Kang2024,
author = {Kang, Xinmei and Chen, Huaxin and Zhou, Zhuowei and Tu, Silin and Cui, Bo and Li, Yanli and Dong, Shuai and Zhang, Qi and Xu, Yan},
title = {Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells},
journal = {Advanced Biology},
year = {2024},
doi = {10.1002/adbi.202300403}
}
EUVIMED